semaglutide compound ending The FDA is drawing a harder line on compounded weight loss drug marketing. In the May–June 2026 issue of Dispense Times, this article breaks down key violations cited in recent FDA enforcement FDA ends GLP-1 compounding for

Neurogenesis in the hippocampus was reduced with WD, but only in males, although GE2 increased neurogenesis in both sexes which depended on diet (under SD in females and WD in males)

Read articleListen Press Release New Mayo Clinic Studies Demonstrate MyPhenome Test Predicts Weight Loss Outcomes Across Treatments, Including GLP-1s and Surgical Interventions PR Newswire - Menlo Park Calif

Others find they need to adjust their workout intensity, especially in the first few days after dose increases when side effects might be stronger

Slowing the movement of food through the stomach (which helps control appetite and promotes fullness)

NHS guidance recommends keeping fat intake to no more than approximately 30% of total daily calories, spread evenly across meals

The molecule was rationally designed by Eli Lilly scientists to simultaneously engage three G-protein-coupled receptors central to metabolic homeostasis: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor